Patent Yard Sign in
Expired Australian patentAustralia

Transgenic autologous T-cell therapy in humans and related compositions and kits

AU 1998094902 · Applicant: Johnson & Johnson Research Pty Limited

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 17, 1998 and granted January 16, 2003. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by September 17, 2019.
  • A pharmaceutical extension adds at most five years, so even that would have ended by September 17, 2024.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 17, 1998
GrantedJanuary 16, 2003
Term ended bySeptember 17, 2019
Application numberAU 1998094902
Classification (IPC)C12N5/10 +2 more

Timeline

Timeline From IP Australia dates

1999200220052008201120142017Application filedSep 17, 1998Patent grantedJan 16, 2003Term ended bySep 17, 2019

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.